A set of proteins have been identified from tumour and blood samples for the diagnosis and prognosis of meningiomas that could predict meningioma severity.
Researchers at IIT Bombay develop a shockwave-based needle-free syringe that ensures painless and safe drug delivery with lesser damage to skin and lower risk of infection
